• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NOTV

NOTV

Inotiv, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD0.12

-0.14 (-53.96%)

Rating:C

Company Profile

CEO

Robert W. Leasure Jr.

IPO Date

1997-11-25

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.16

Prev. Close

$0.26

Day Low

$0.10

Day High

$0.16

52W Low

$0.10

52W High

$3.32

Market Cap

$0.00B

Volume

21.98M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

16.0%

Avg Negative

3.7%

Avg Neutral

80.4%

News Feed

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

GlobeNewsWire·7/15/2021·↓ negative

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma's BioReliance® portfolio

GlobeNewsWire·7/12/2021·↑ positive

Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort

GlobeNewsWire·6/28/2021·↑ positive

Inotiv Set to Join Russell 3000® Index and Russell 2000® Index

GlobeNewsWire·6/7/2021·↑ positive

Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity

GlobeNewsWire·5/27/2021·↑ positive

Inotiv, Inc. (NOTV) CEO Robert Leasure on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·5/8/2021·↓ negative

Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results

GlobeNewsWire·5/5/2021·↑ positive

Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.

GlobeNewsWire·4/30/2021·↑ positive

Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021

GlobeNewsWire·4/26/2021·↑ positive

Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

GlobeNewsWire·4/23/2021·↑ positive